Evidence map›Paper›PMID 38081671›Full record

ArticleBMJ open2023

Experiences of using artificial intelligence in healthcare: a qualitative study of UK clinician and key stakeholder perspectives.

C A Fazakarley, Maria Breen, Paul Leeson, Ben Thompson, Victoria Williamson

Registry-linked trialAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05028179 (PROTEUS), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05028179 naunknown statusnot on this map

PROTEUS: A PROspective Randomised Controlled Trial Evaluating the Use of Artificial Intelligence in Stress Echocardiology

TypeinterventionalSponsorUltromics LtdRan2021 to 2023Enrolled2,338ConditionsCoronary Heart DiseaseArmsEchoGo
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Use of Direct-to-Consumer Telemedicine: A Qualitative Study Exploring the Thoughts, Perspectives and Experiences of Australian Adults.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

C A FazakarleyUltromics Ltd, Oxford, UK.
Maria BreenSchool of Psychology & Clinical Language Sciences, University of Reading, Reading, UK.
Paul LeesonDivision of Cardiovascular Medicine, University of Oxford, Oxford, UK.
Ben ThompsonUltromics Ltd, Oxford, UK.
Victoria WilliamsonKing's College London, London, UK victoria.williamson@kcl.ac.uk.ORCID 0000-0002-3110-9856

Funding

Medical Research Council MR/W003686/1
6 · The paper itself

Abstract

objectivesArtificial intelligence (AI) is a rapidly developing field in healthcare, with tools being developed across various specialties to support healthcare professionals and reduce workloads. It is important to understand the experiences of professionals working in healthcare to ensure that future AI tools are acceptable and effectively implemented. The aim of this study was to gain an in-depth understanding of the experiences and perceptions of UK healthcare workers and other key stakeholders about the use of AI in the National Health Service (NHS).

designA qualitative study using semistructured interviews conducted remotely via MS Teams. Thematic analysis was carried out.

settingNHS and UK higher education institutes.

participantsThirteen participants were recruited, including clinical and non-clinical participants working for the NHS and researchers working to develop AI tools for healthcare settings.

resultsFour core themes were identified: positive perceptions of AI; potential barriers to using AI in healthcare; concerns regarding AI use and steps needed to ensure the acceptability of future AI tools. Overall, we found that those working in healthcare were generally open to the use of AI and expected it to have many benefits for patients and facilitate access to care. However, concerns were raised regarding the security of patient data, the potential for misdiagnosis and that AI could increase the burden on already strained healthcare staff.

conclusionThis study found that healthcare staff are willing to engage with AI research and incorporate AI tools into care pathways. Going forward, the NHS and AI developers will need to collaborate closely to ensure that future tools are suitable for their intended use and do not negatively impact workloads or patient trust. Future AI studies should continue to incorporate the views of key stakeholders to improve tool acceptability. TRIAL REGISTRATION NUMBER: NCT05028179; ISRCTN15113915; IRAS ref: 293515.

Indexed as

Artificial IntelligenceState MedicineAcademies and InstitutesHumansQualitative ResearchUnited Kingdomclinical decision-makingqualitative researchquality in health care

Identifiers

PMID38081671
PMCPMC10729128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.